FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

cobas liat SARS-CoV-2 v2 nucleic acid test

K Number: K243346 · Decision Apr 11, 2025
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
2
Applicant Total
51
Review Days
165

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
cobas liat SARS-CoV-2 v2 nucleic acid test
K Number
K243346
Device Class
FDA class 2
Clearance Type
Dual Track
Regulation Number
866.3982
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Molecular Systems, Inc.
Date Received
October 28, 2024
Decision Date
April 11, 2025
Product Code
QWR
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QWR Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QWR), ordered by most recent decision date.

View all

Other Clearances by Roche Molecular Systems, Inc.

K Number Device Name
K253756 cobas liat CT/NG nucleic acid test
K253759 cobas liat CT/NG/MG nucleic acid test
K243753 cobas liat Bordetella panel nucleic acid test
K252484 cobas HCV
K252481 cobas CMV
K243455 cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems
K243863 Opulus™ Lymphoma Precision
K243400 cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test
K243406 cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
K240867 cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
Search all 51 clearances from Roche Molecular Systems, Inc. →